Pro-inflammatory role of monocyte-derived CX3CR1int macrophages in Helicobacter hepaticus-induced colitis by Bain, Calum C et al.
This is an author produced version of Pro-inflammatory role of monocyte-derived 
CX3CR1int macrophages in Helicobacter hepaticus-induced colitis.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/126064/
Article:
Bain, Calum C, Oliphant, Christopher J, Thomson, Carolyn A et al. (2 more authors) (2017)
Pro-inflammatory role of monocyte-derived CX3CR1int macrophages in Helicobacter 
hepaticus-induced colitis. Infection and Immunity. pp. 1-31. ISSN 1098-5522 
https://doi.org/10.1128/IAI.00579-17
promoting access to
White Rose research papers
eprints@whiterose.ac.uk
http://eprints.whiterose.ac.uk/
 1 
Pro-inflammatory role of monocyte-derived CX3CR1int macrophages in Helicobacter 2 
hepaticus-induced colitis  3 
Calum C. Bain1,3#, Christopher J. Oliphant2,4, Carolyn A. Thomson1, Marika C. Kullberg2# and 4 
Allan McI. Mowat1 5 
 6 
1Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, University of 7 
Glasgow, UK 8 
2Centre for Immunology and Infection, Department of Biology and Hull York Medical School, 9 
University of York, UK 10 
3Present address: MRC Centre for Inflammation Research, University of Edinburgh, UK 11 
4Present address: Biosceptre Ltd, Cambridge, UK. 12 
 13 
#
 Corresponding authors: Marika C. Kullberg and Calum C. Bain 14 
Running title: Myeloid cells in H. hepaticus colitis 15 
 16 
 17 
 18 
 19 
  20 
IAI Accepted Manuscript Posted Online 4 December 2017
Infect. Immun. doi:10.1128/IAI.00579-17
Copyright © 2017 Bain et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
 o
n
 January 9, 2018 by UNIV O
F YO
RK
http://iai.asm
.org/
D
ow
nloaded from
 
 2 
ABSTRACT 21 
Cells of the monocyte-macrophage lineage play important roles in the pathogenesis of 22 
inflammatory bowel diseases, but they are also present in the normal healthy intestine, where 23 
they are critical for maintaining homeostasis. It has been unclear whether the pro-24 
inflammatory roles of intestinal macrophages reflect altered behaviour of the existing resident 25 
cells, or if they involve recruitment of a distinct cell type. Here we have explored these ideas 26 
using the model of colitis induced by Helicobacter hepaticus (Hh) in the context of 27 
neutralisation or deletion of interleukin 10 (IL-10). Granulocytes and monocytes made up 28 
most of the inflammatory myeloid infiltrates found in the colon of Hh-infected colitic mice, 29 
rising to a peak within 2 weeks of Hh inoculation, but taking several months to resolve 30 
completely. The inflammatory response was dependent on the combined presence of Hh and 31 
absence of IL-10, and was accompanied by increased production of inflammatory mediators 32 
such as IL-1E, TNFD, IL-6 and IL-23p19 by infiltrating myeloid cells, mostly relatively 33 
immature cells of the macrophage lineage that express intermediate levels of CX3CR1. In 34 
contrast, the population of mature CX3CR1hi macrophages did not expand as markedly during 35 
colitis, and these cells made little contribution to inflammatory mediator production. Taking 36 
into account their numerical dominance in the myeloid compartment, we conclude that newly 37 
recruited monocytes are the main source of pro-inflammatory mediators in colitis induced in 38 
the absence of IL-10 signalling, and that altered behaviour of mature macrophages is not a 39 
major component of this pathology. 40 
 41 
  42 
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 3 
INTRODUCTION 43 
Inflammatory bowel diseases ,%' FRPSULVLQJ &URKQ¶V GLVHDVH DQG XOFHUDWLYH FROLWLV are 44 
growing health problems in the developed world. Although recent advances have helped 45 
elucidate some of the mechanisms underlying IBD, treatment remains unsatisfactory and 46 
individual regimes are seldom effective for all patients. Thus, a better understanding of the 47 
processes and cells involved in the pathogenesis of IBD could help develop new targets for 48 
therapy. 49 
Macrophages (mø) have received considerable attention in recent years because of 50 
their potential roles in both steady-state and inflamed intestine (1-3). Resident møs are 51 
abundant in the healthy intestine, where they are involved in clearance of apoptotic cells and 52 
play a crucial role in maintaining homeostasis, ingesting and killing commensal bacteria that 53 
cross the epithelial barrier (reviewed in (2)). In contrast to other tissues, these processes do 54 
not provoke overt inflammation in the intestine, due to powerful control mechanisms that 55 
prevent local mø from producing pro-inflammatory mediators in response to stimuli such as 56 
TLR ligands (4, 5). However, findings from both IBD and experimental models of the disease 57 
have demonstrated that møs are also crucial components of the inflammatory infiltrate (4, 6-58 
9), raising the possibility of exploiting them as therapeutic targets. 59 
We and others have shown recently that intestinal mø originate from Ly6Chi blood 60 
monocytes that continuously enter the colonic mucosa and differentiate locally through a 61 
series of intermediaries. Although only present in small numbers, cells with the phenotypic 62 
and morphological features of Ly6Chi monocytes can be found in the steady state mucosa. 63 
However, major transcriptional differences exist between these and Ly6Chi monocytes found 64 
in blood, suggesting that the differentiation process occurs immediately after monocytes enter 65 
the colonic mucosa (6, 10). Importantly, as monocytes mature they progressively acquire anti-66 
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 4 
inflammatory properties, such as constitutive production of IL-10 and hyporesponsiveness to 67 
e.g. TLR ligands  (6, 11, 12). However, this physiological process is disrupted during 68 
inflammation (6, 12, 13), and understanding of how this change in mø behaviour occurs would 69 
be an important advance in our knowledge of how to prevent and treat IBD. Studies of the 70 
colitis induced by feeding dextran sodium sulphate (DSS) suggest that the tissue pathology is 71 
paralleled by the accumulation of highly pro-inflammatory monocytes, whereas the fully 72 
differentiated møs that remain do not alter their behaviour and retain their anti-inflammatory 73 
characteristics (6, 12). However, it is not clear if this pattern extends to other forms of 74 
intestinal inflammation, particularly under conditions where there are intrinsic defects in the 75 
mechanisms that normally control resident mø function. 76 
The IL-10 ± IL-10R axis is an important brake on mø activation, particularly in the 77 
intestine, where deletion of either the cytokine or its receptor leads to spontaneous onset of 78 
inflammation in association with hyper-responsiveness of mø (13-19). Furthermore, humans 79 
with non-functional mutations in IL10, IL10RA, or IL10RB develop severe enterocolitis within 80 
the first months of life (reviewed in (20)). Here we have examined the relationship between IL-81 
10 and the differentiation of intestinal mø in inflammation in more depth by exploring mø 82 
behaviour during colitis induced by inoculation of mice with Helicobacter hepaticus (Hh) in the 83 
absence of IL-10 signalling (21, 22).  We report that Hh-induced colitis is characterized by the 84 
accumulation of pro-inflammatory CD11b+ myeloid cells that are hyper-responsive to TLR 85 
stimulation. Most of these cells are monocytes and their immediate progeny that express 86 
intermediate levels of CX3CR1 and that have not differentiated fully into anti-inflammatory, 87 
resident-type CX3CR1hi mø. We further show that the expansion of cells in the monocyte-mø 88 
compartment is maintained for several months before returning to normal levels as the 89 
inflammation resolves.   90 
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 5 
MATERIALS AND METHODS 91 
Infection and antibody treatment of mice 92 
Female C57BL/6 (B6) Il10±/±, B6 WT, B6 CD45.1+ Cx3cr1gfp/gfp mice (obtained from Jackson 93 
Laboratory), and B6 CD45.1+ Cx3cr1+/gfp (generated by crossing Cx3cr1gfp/gfp mice with B6 94 
CD45.1+ WT animals) were bred and maintained in an accredited SPF facility, and the 95 
experiments were conducted in accordance with the UK Animals (Scientific Procedures) Act 96 
1986 under a Project License authorized by the UK Home Office and approved by the 97 
University of York Animal Welfare and Ethical Review Body. The mice tested negative for 98 
antibodies to specific murine viruses, were free of Helicobacter spp. as assessed by PCR, 99 
and were >6-weeks old when used.  100 
Mice were allocated to treatment groups and inoculated i.g. with 1.5 x 107 Hh NCI-101 
Frederick isolate 1A (23), derived originally from the same mouse colony as isolate Hh-1 (24) 102 
(American Type Culture Collection strain 51449). IL-10-sufficient mice were also treated i.p. 103 
with 1 mg of anti-IL-10R (clone 1B1.3a) on days 0, 7, 14, 21, 28, 35, 42, 49, 56, 63, and 70 of 104 
Hh infection. Age- and sex-matched uninfected animals were included as controls. One week 105 
after the last mAb injection, mice were sacrificed and intestines collected for analysis.  106 
 107 
Lamina propria (LP) cell isolation 108 
For the experiments shown in Figures 1 and 2, colon and caecum were pooled from individual 109 
mice and digested with Liberase Cl (0.42 mg/ml, Roche, Burgess Hill, UK) and DNase I (125 110 
U/ml; Sigma-Aldrich, Gillingham, UK), followed by enrichment of LP cells on 40/80% Percoll 111 
gradients as described previously (25). For the experiments shown in Figures 3-5 and in 112 
Supplementary Figures, colonic LP cells were isolated as described previously without the 113 
use of Percoll gradients (4, 26). 114 
 o
n
 January 9, 2018 by UNIV O
F YO
RK
http://iai.asm
.org/
D
ow
nloaded from
 
 6 
 115 
Flow cytometric analysis and FACS 116 
After blocking Fc receptors with anti-FcJRII/III mAb (2.4G2; BD Biosciences), LP cells were 117 
stained at 4°C with fluorochrome-conjugated antibodies (see Table S1) for 20-30 min in the 118 
dark before being washed in FACS buffer (2% FCS and 1mM EDTA in PBS) and then 119 
analyzed on a CyAn ADP (Beckman Coulter, High Wycombe, UK) or LSRII/FACSAria I (BD 120 
Bioscience) flow cytometer. Data were analyzed using FlowJo software (Tree Star Inc. OR, 121 
USA). Myeloid cell populations (as defined in figure legends) were sorted using a MoFlo 122 
Astrios or a FACSAria I sorter, with purities of >96%. For flow cytometric analyses on BD 123 
instruments, automatic compensation was performed in FACSDiva using UltraComp or 124 
OneComp beads together with fluorescence minus one controls.   125 
 126 
Intracellular cytokine staining (ICS) 127 
Large intestinal LP cells (2 x 106/ml) from uninfected and 2-week Hh-infected Il10±/± mice 128 
were cultured in medium alone or in the presence of 10 Pg/ml Pam3CSK4 (Invivogen, 129 
Toulouse, France) for 4 hr at 37°C with 10 Pg/ml brefeldin A during the last 3 hr. Thereafter, 130 
cells were stained for surface markers (CD45 and CD11b) and intracellular TNF-D as 131 
described previously (25). 132 
 133 
Analysis of cytokine protein and mRNA expression 134 
For cytokine protein analysis, FACS-purified CD45+CD11b+ cells were cultured in 96-well 135 
round-bottomed plates (5x104/ml; 0.2ml/well) at 37°C and 5% CO2 in medium alone or with 10 136 
Pg/ml ultrapure E. coli LPS, 10 Pg/ml Pam3CSK4 (both from Invivogen, Toulouse, France) or 137 
10 Pg/ml soluble Hh antigen (SHelAg) prepared as described (21, 27). After 24 hr, 138 
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 7 
supernatants were collected and analyzed by ELISA for IL-12p40 (Mabtech, Nacka Strand, 139 
Sweden) and IL-6 (R&D Systems), and by FlowCytomix for TNF-D (Bender MedSystems, 140 
Vienna, Austria).   141 
 For cytokine RT-qPCR analysis in Fig. 2, FACS-purified CD45+CD11b+ cells were 142 
homogenized in TRIzol, and total RNA isolated by chloroform extraction and reverse 143 
transcribed using SuperScript II and random hexamers. cDNA was amplified using SYBR 144 
green reagents and an ABI Prism RT-PCR system (Applied Biosystems). Cytokine expression 145 
levels for each individual sample (run in duplicates) were normalized to HPRT using 'Ct 146 
calculations and the 7000 system SDS software (Applied Biosystems). For myeloid cell 147 
populations in Fig. 5, FACS-purified cells were lysed in RLT buffer (Qiagen) and 148 
homogenised using Qiashredders (Qiagen). RNA was then isolated and purified using an 149 
RNeasy micro kit (Qiagen) and reverse transcribed using a High Capacity RNA-to-cDNA kit 150 
(Life Technologies) and random hexamers. cDNA was amplified using SYBR green reagents 151 
and an ABI 7900HT Prism RT-PCR system (Applied Biosystems). Cytokine expression levels 152 
for each individual sample (run in triplicates) were normalized to TBP using 'Ct calculations. 153 
Specific primers pairs are detailed in Table S2.  154 
 155 
Statistical analysis 156 
Multiple group comparisons were performed by one-way ANOVA, while 6WXGHQW¶V W-test and 157 
Mann Whitney test was used to compare two groups. Differences were considered 158 
statistically significant with P<0.05. 159 
160 
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RESULTS 161 
Expansion of myeloid cells in the large intestine of Hh-infected colitic Il10±/± mice.  162 
To begin to characterize the innate immune response in the large intestine following Hh 163 
inoculation, WT and Il10±/± mice were inoculated i.g. with the bacterium, and the cellular 164 
composition of LP cells from pooled ceca and colons was examined 2 weeks later, the time 165 
point at which pathology peaks in Il10±/± hosts (25). As expected, Hh-infected Il10±/± mice 166 
displayed enhanced cellularity of the large intestinal LP compared with uninfected controls 167 
(Fig. 1A, left panel), with greatly expanded proportions and numbers of CD45+ hematopoietic 168 
cells (Fig. 1A, middle and right panels), consisting of B cells, CD4+ T cells, and CD11b+ 169 
myeloid cells (Fig. 1B). Only minor increases were observed in the proportion and number of 170 
LP CD45+ cells in Hh-infected WT mice (Fig. 1A), and the size of CD11b+ myeloid 171 
compartment was unaffected in these hosts (Fig. 1B, right panel). More detailed analysis of 172 
the early cellular kinetics following Hh inoculation of Il10±/± animals revealed that the numbers 173 
of total CD45+ cells and of CD11b+ myeloid cells were significantly increased in Hh-infected 174 
Il10±/± mice on day 5 pi, and expanded steadily until day 11 pi (Fig. 1C). Thus, Hh-driven 175 
typhlocolitis in Il10±/± mice is associated with massive infiltration by both lymphoid and 176 
myeloid cells. 177 
 178 
Myeloid cells from Hh-infected Il10±/± mice display a pro-inflammatory phenotype 179 
To understand how the expansion of the myeloid compartment might contribute to the colitis 180 
in Il10±/± hosts, we examined the cytokine secretion profile of CD11b+ cells from uninfected 181 
and Hh-infected Il10±/± mice. To this end, large intestinal LP cells were stimulated with the 182 
TLR ligand Pam3CSK4, and TNFD production examined by intracellular cytokine staining 183 
(ICS). TLR ligation of LP cells from Hh-infected Il10±/± animals resulted in ~3-fold increase in 184 
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 9 
the proportion of CD11b+ cells producing TNFD compared with cells cultured in medium alone 185 
(Fig. 2A, bottom panels), and this translated to a highly significant increase in the absolute 186 
number of TNFD+CD11b+ cells in the LP of infected Il10±/± mice compared with uninfected 187 
controls (Fig. 2B). In contrast, the proportion of TNFD+ CD11b+ cells from uninfected Il10±/± 188 
animals was unaffected by Pam3CSK4 stimulation and remained at levels similar to those 189 
seen in naïve WT colon (Fig. 2A, upper panels and Fig. 2B). 190 
 To extend these analyses, we next FACS-purified CD11b+ cells from the large 191 
intestinal LP of uninfected and 2-week Hh-infected Il10±/± animals and cultured them overnight 192 
with LPS, Pam3CSK4, or soluble Hh antigen (SHelAg), before assessing the levels of a wider 193 
range of cytokines using ELISA and FlowCytoMix. CD11b+ cells from Hh-infected Il10±/± mice 194 
secreted higher amounts of IL-12p40, IL-6, and TNFD after all forms of stimulation compared 195 
with CD11b+ cells from uninfected Il10±/± hosts (Fig. 2C). When analysed directly ex vivo, 196 
FACS-purified CD11b+ cells from Hh-infected Il10±/± mice also contained higher levels of Il12a 197 
and Il23a transcripts compared with CD11b+ cells from uninfected controls, whereas the 198 
levels of Il12b accumulation were similar in the two populations (Fig. 2D). Thus, the expanded 199 
myeloid cell compartment in the large intestine of Hh-infected colitic Il10±/± mice displays pro-200 
inflammatory characteristics.  201 
 202 
Composition of the myeloid compartment in Hh-infected Il10±/± mice 203 
We next set out to explore what cell types accounted for the change within the CD11b+ 204 
compartment during Hh colitis. To do this, we exploited multiparameter flow cytometry and 205 
rigorous gating strategies we have developed recently to characterise the myeloid 206 
compartment of the intestinal LP, allowing precise identification of monocytes, mø, 207 
eosinophils, neutrophils and dendritic cells (DC) ((6); Fig. S1). We also omitted the Percoll 208 
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gradient step during the purification to exclude the possibility of selective loss of individual cell 209 
types. These approaches confirmed marked changes in the composition of the myeloid cell 210 
compartment in the colon 2 weeks after Hh inoculation of Il10±/± mice, compared with 211 
uninfected Il10±/± mice or Hh-infected WT mice (Fig. 3A). Ly6G+ neutrophils and SSChi 212 
(MHCII±) eosinophils (Figs. 3A, B and C) accounted for a substantial part of the infiltration 213 
found in Hh-infected Il10±/± mice and no significant differences were seen in these granulocyte 214 
populations in Hh-infected WT mice, or in uninfected Il10±/± mice compared with uninfected 215 
WT mice (Figs. 3A, B, and C). 216 
Hh-infected Il10±/± mice also showed marked expansion in the numbers of non-217 
granulocytic myeloid cells (Figs. 3A, D and E), and we therefore explored the contribution of 218 
monocytes and mø in more detail. To do this, we focused on cells expressing the pan-mø 219 
markers F4/80 and/or CD64 (Fig. S1) and examined the monocyte-mø differentiation 220 
continuum that we and others have defined in the colonic LP (6, 28, 29). This so-called 221 
µPRQRF\WH ZDWHUIDOO¶ consists of newly arrived Ly6ChiMHCII± monocytes, differentiating 222 
Ly6C+MHCII+ monocytes, and more mature Ly6C±MHCII+ cells that include tissue-resident mø 223 
(Fig. 3D). Hh-infected Il10±/± mice showed marked increases in the proportions and absolute 224 
numbers of Ly6ChiMHCII± and Ly6C+MHCII+ cells, which were increased by ~125-fold and 225 
155-fold respectively compared with their numbers in uninfected Il10±/± mice (Figs. 3D and E). 226 
There was also a modest, but significant increase in the number of more mature Ly6C±227 
MHCII+ cells in Hh-infected Il10±/± mice (Fig. 3E, right panel). Hh-infected WT mice, which do 228 
not develop colitis, showed some evidence of increased infiltration by Ly6ChiMHCII±, 229 
Ly6C+MHCII+ and Ly6C± cells, while uninfected Il10±/± mice had slightly higher numbers of 230 
Ly6C+MHCII+ cells compared with their naïve WT counterparts; however, these differences 231 
were modest and did not attain statistical significance (Fig. 3E).  232 
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 11 
DCs were identified as CD11c+MHCII+CD64± cells amongst LP leukocytes (30) and 233 
their numbers increased in Hh-infected compared to control Il10±/± mice (Fig. S2A). The 234 
frequency of DCs among LP cells of Hh-infected Il10±/± mice decreased compared to 235 
uninfected controls (data not shown), most likely reflecting the increase in other leukocytes. 236 
Finally, there were minor changes in the proportion of DC subsets identified on the basis of 237 
CD11b and CD103 expression, although none of these changes reached statistical 238 
significance (Fig. S2B).  239 
 240 
Altered monocyte - mø differentiation in Hh-infected colitic mice 241 
The accumulation of monocytes we found in Hh colitis is reminiscent of our own and other 242 
results from DSS and T-cell-mediated colitis, where there appeared to be an arrest in the 243 
local differentiation continuum that normally generates anti-inflammatory, resident mø (6, 12, 244 
28). To examine whether a similar block was present during Hh-induced colitis, we used 245 
Cx3cr1+/gfp reporter mice in which one allele of the Cx3cr1 gene has been replaced with the 246 
gene encoding green fluorescent protein (GFP) (31). This allows fully differentiated resident 247 
CX3CR1hi mø to be distinguished from cells in the earlier CX3CR1int stages in the 248 
developmental continuum, some of which would have been included amongst the Ly6C±249 
MHCII+ population we defined earlier. In this way, we could examine the relative roles of 250 
resident and recently recruited mø in Hh-induced inflammation, as well as explore how these 251 
cells behave during the resolution of pathology that occurs at later stages after bacterial 252 
inoculation (25). Because the Cx3cr1+/gfp reporter mice are IL-10 sufficient, we had to induce 253 
colitis by Hh inoculation plus weekly administration of anti-IL-10R mAb (22). Consistent with 254 
our studies in Il10±/± mice, this resulted in massive accumulation of total leukocytes and 255 
CD11b+ myeloid cells in the colonic mucosa by day 14 pi (Figs. 4A and B). However, by day 256 
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41 pi, both compartments had contracted significantly, and by day 77 pi they were both 257 
reduced almost to baseline levels (Figs. 4A and B).  258 
As in colitic Il10±/± mice, the composition of the myeloid compartment was markedly 259 
altered in anti-IL-10R-treated Hh-infected Cx3cr1+/gfp mice, with a large expansion of 260 
granulocytes and monocyte-derived cells at day 14 pi, followed by resolution at later times 261 
(Fig. 4C). Moreover, the non-granulocyte component of the myeloid infiltrate contained large 262 
numbers of Ly6ChiMHCII± and Ly6C+MHCII+ cells at day 14 pi (Figs. 4C-E). The Ly6C±MHCII+ 263 
population also expanded in number early in colitis, but most of this expansion was accounted 264 
for by CX3CR1int cells (Fig. 4F), a population that we have shown previously to be a further 265 
intermediary stage in the local differentiation of monocytes (6). In parallel, there was a 266 
substantial decrease in the proportion of fully-mature CX3CR1hi mø amongst the Ly6C± 267 
MHCII+ cells at this time (Fig. 4F), although their absolute numbers were increased and 268 
remained so throughout the experiment (Fig. 4G). By day 41 pi, the proportions and numbers 269 
of CX3CR1int cells amongst Ly6C±MHCII+ cells had contracted significantly, and by day 77 pi, 270 
CX3CR1hi cells had again come to dominate the Ly6C± mature mø compartment (Fig. 4F & 271 
G). At this time the numbers of Ly6ChiMHCII± and Ly6C+MHCII+ cells had also returned to 272 
baseline levels (Fig. 4E).  273 
The numbers of Ly6G+ neutrophils and CD11c+CD11b+F4/80± DC were greatly 274 
increased by day 14 pi in anti-IL-10R-treated Hh-infected Cx3cr1+/gfp mice, before falling at 275 
later times in parallel with the reduction in monocytes and mø (Fig. S3A and B). Interestingly 276 
however, the numbers of colonic eosinophils remained high in these mice until the end of the 277 
experiment on day 77 pi (Fig. S3C). All these Hh-induced changes in myeloid cells were seen 278 
only when Hh-infected Cx3cr1+/gfp mice were also co-administered with anti-IL-10R (Fig. 4 and 279 
data not shown). Anti-IL-10R treatment alone of uninfected Cx3cr1+/gfp mice did not result in 280 
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leukocyte accumulation in the colonic mucosa (Fig. S4), findings that are in agreement with 281 
those we previously reported for uninfected WT mice (22). 282 
Together our results demonstrate that the acute phase of Hh-induced colitis is 283 
associated with accumulation of CX3CR1int monocytes and early-stage mø, consistent with 284 
the idea that there may be a block in the normal differentiation process. 285 
 286 
Colonic CX3CR1int monocytes/møs are the major producers of pro-inflammatory 287 
cytokines during Hh colitis 288 
Finally we explored whether elicited CX3CR1int cells were responsible for the production of 289 
pro-inflammatory mediators by myeloid cells during colitis, or if this reflected altered behaviour 290 
of the more mature CX3CR1hi mø. RT-qPCR analysis showed marked upregulation of mRNA 291 
transcripts for Il1b, Nos2 (iNOS), Il23p19 and Il12p35 in CX3CR1int cells from anti-IL-10R-292 
treated Hh-infected mice at the peak of inflammation on day 14 compared with CX3CR1int 293 
cells from control mice (Fig. 5A-D). In contrast, colonic CX3CR1hi mø from anti-IL-10R-treated 294 
Hh-infected mice showed only minor changes in mRNA levels of pro-inflammatory mediators 295 
(Fig. 5). Thus, taking into account their numerical dominance in the myeloid compartment, 296 
newly recruited CX3CR1int monocytes/møs form the predominant pro-inflammatory population 297 
in this model of colitis.  298 
 299 
DISCUSSION 300 
 301 
The results presented here underline the importance of the myeloid compartment in the 302 
inflammatory colitis that occurs in mice infected with Helicobacter hepaticus when IL-10-303 
mediated signalling is absent. Using a variety of approaches to identify myeloid lineages, 304 
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including Cx3cr1+/gfp mice, we show that an intense infiltrate of CD11b+ cells appears early 305 
during infection and that this is made up of neutrophils, eosinophils, Ly6ChiMHC±/+ monocytes 306 
and CX3CR1int mI at the time of peak disease at 2 weeks after Hh inoculation. While this 307 
confirms other work (32), we also show here that this expansion of the monocyte-mI 308 
compartment is sustained for up to 11 weeks after infection, by which time other parameters 309 
of inflammation, such as changes in myeloid cell subset composition, have returned to 310 
steady-state levels. Importantly, the inflammatory changes required both infection with Hh and 311 
neutralisation of IL-10R signalling, with very few changes being seen in mice with Hh infection 312 
alone or loss of IL-10 alone. Similarly, the greatly heightened production of pro-inflammatory 313 
mediators in response to activation in vitro by intestinal myeloid cells was fully dependent on 314 
these factors operating together. These results confirm previous conclusions that Hh plays a 315 
crucial role in provoking intestinal inflammation in the absence of IL-10-mediated 316 
immunoregulation and that pro-inflammatory responses to this organism are normally 317 
restrained by IL-10 (21, 22, 33).  318 
 In previous work, we have shown that resident mI in normal intestinal mucosa are 319 
replenished continuously by Ly6Chi monocytes that differentiate via a number of intermediary 320 
stages into mature, resident mI (6, 11, 28). At early times after inoculation with Hh, this so-321 
called monocyte-mI ³waterfall´ expanded dramatically, and consisted mostly of Ly6ChiMHCII±322 
/+
 monocytes and CX3CR1int mI, with less expansion of fully mature CX3CR1hi mI. Although 323 
these findings are consistent with previous work, e.g. in chemically-induced colitis (6), and 324 
suggest that the normal process of monocyte-mI differentiation is arrested, it is important to 325 
note that the absolute numbers of mature mI were actually increased in our mice with Hh-326 
induced colitis and remained so for the duration of the 11-week experiment. Thus, although 327 
the majority of infiltrating monocytes may be short-lived in the colitic mucosa, a proportion of 328 
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these cells may still develop into mature CX3CR1hi mI, even in the face of inflammation. How 329 
the mI recruited under these conditions might contribute to the inflammation or its resolution 330 
and if they eventually acquire all the properties of the normal, resident population remain to 331 
be determined, as do the relative contributions of newly recruited and pre-existing cells to the 332 
³UHVLGHQW´PI compartment.  333 
Although methods were not available to examine and track infiltrating monocytes 334 
directly following their arrival in the gut, we were able to explore whether the total mature mI 335 
population was altered in function during Hh colitis. In steady-state intestine, resident mI 336 
exhibit an anti-inflammatory phenotype characterised by constitutive production of IL-10 and 337 
low levels of TNFD, together with an inability to respond to stimuli such as TLR ligands, but it 338 
has been unclear whether these properties can change during inflammation (34). In contrast 339 
to their CX3CR1hi counterparts, as we show here, cells within the CX3CR1int compartment are 340 
actively pro-inflammatory, expressing much higher levels of mRNA for pro-inflammatory 341 
mediators such as IL1E, iNOS, IL-23, and IL-12 during Hh colitis than their control 342 
counterparts. In parallel, CX3CR1hi mI taken at the peak of inflammation showed no 343 
increased expression of IL-1E or IL-12 mRNA, and only a modest increase in iNOS and IL-23 344 
mRNA, suggesting some, but limited ability to adopt a pro-inflammatory phenotype under 345 
these circumstances. In DSS colitis, we and others have shown that resident mI do not 346 
acquire pro-inflammatory characteristics (6, 12), but this has been reported in models of colitis 347 
where IL-10-mediated signalling is absent, with wider alterations in gene expression than we 348 
tested here (18). While this contrasting behaviour in the presence and absence of IL-10 is yet 349 
to be confirmed in other models of inflammation, the results are consistent with recent 350 
evidence that IL-10 drives permanent, epigenetic silencing of pro-inflammatory genes (35). As 351 
a result, the absence of IL-10R-mediated signalling profoundly alters the genetic landscape of 352 
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mature intestinal mI, allowing them to respond to stimuli to which they are normally resistant 353 
(18). Whether IL-10 also controls other aspects of intestinal mI differentiation is unclear, 354 
although it has been reported that their expression of the scavenger receptor CD163 is 355 
dependent on IL-10 (14). Arnold et al. showed reduced levels of CD206 on CX3CR1hi mI in 356 
Hh colitis (32), but it is not clear whether this reflects an intrinsic effect of IL-10, or is 357 
secondary to the effects of inflammation.  That resident mI retain a substantial proportion of 358 
their homeostatic properties in the absence of IL-10 is suggested by our finding that sustained 359 
expansion of this population is not accompanied by maintenance of Hh-dependent 360 
immunopathology. 361 
The colitis induced by Hh is dependent on IL-23 (22) and upregulation of this cytokine 362 
was one of the major changes we and others observed in CX3CR1intCD11b+ myeloid cells in 363 
this model (32). It has often been difficult to identify precisely the cell responsible for 364 
producing IL-23 in infection or inflammation, in great part because mI and DC share many 365 
phenotypic features such as CD11c, MHCII, CX3CR1 and CD11b. Therefore it is important to 366 
note that by using rigorous gating strategies based on CD64 as a mI marker, both we and 367 
Arnold et al. (32) show that IL-23 was derived from the mI lineage, which is consistent with 368 
work in other models (7, 36, 37). Notably, however, we detected increased IL-12p35 and IL-369 
23p19 transcript levels in elicited CX3CR1int monocyte/mIs, suggesting that these cells 370 
produce both IL-12 and IL-23 during Hh-induced intestinal inflammation. Thus we propose 371 
that the TH17 response and subsequent phenotype switching of Th17 cells into IFN-J+IL-17A+ 372 
lymphocytes in Hh colitis (24) is driven by IL-23 derived from mI, presumably activated 373 
directly by products of the organism. Nevertheless it should be noted that both 374 
CD103+CD11b+ and CD103±CD11b+ DC from the intestine have been shown to be capable of 375 
driving TH17 responses in vivo and in vitro respectively, via production of IL-23 and/or IL-6 376 
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(30, 38-40). Thus there may be flexibility between the mI and DC lineages in their ability to 377 
stimulate TH17 activity depending on the stimulus. Alternatively, these cell types may 378 
cooperate in driving such T-cell responses, perhaps with migratory DC being responsible for 379 
priming TH17 cells in the draining lymph node, while tissue resident mI may sustain the 380 
survival of these cells once they migrate back to the mucosa (41). 381 
Together our results show that elicited monocyte-derived CX3CR1int macrophages 382 
form the predominant pro-inflammatory macrophage population in Hh-induced colitis. Given 383 
that these cells appear to derive from the same Ly6Chi blood monocytes as their homeostatic 384 
counterparts, identifying the factors that govern monocyte fate in the colon during 385 
homeostasis versus inflammation could provide new therapeutic targets for the treatment for 386 
IBD. 387 
  388 
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 553 
FIGURE LEGENDS 554 
Figure 1. Expansion of myeloid cells in the large intestine of Hh-infected colitic Il10±/± 555 
mice. WT and Il10±/± mice were inoculated with Hh, and LP cells were isolated from pooled 556 
caecum and colon 2 weeks (A-B) or 1, 3, 5, 8, and 11 days (C) later and examined by flow 557 
cytometry. Uninfected mice were included as controls. (A) Total numbers of LP cells (left 558 
panel), percentage (middle panel) and total numbers (right panel) of CD45+ hematopoietic 559 
cells from uninfected (white bars) and 2-week Hh-infected (black bars) WT and Il10±/± mice. 560 
(B) Numbers of B220+CD19+ B cells (left panel), CD3+CD4+ T cells (middle panel), and 561 
CD11b+ myeloid cells (right panel) from uninfected (white bars) and 2-week Hh-infected 562 
(black bars) WT and Il10±/± mice. Data in A-B are from one representative experiment out of 563 
at least three performed, and bars represent mean + SD of 3 mice per group. (C) Total 564 
numbers of LP cells (left panel), CD45+ hematopoietic cells (middle panel) and CD11b+ cells 565 
(right panel) from pooled caecum and colon of 1-, 3-, 5-, 8-, and 11-day Hh-infected Il10±/± 566 
mice. Data are pooled from two individual experiments, and are the mean + SD of 5-6 LP cell 567 
preparations (each pooled from 1-2 animals) from Hh-infected mice and 8 cell preparations 568 
(each pooled from 2-3 animals) from uninfected mice. One-ZD\$129$IROORZHGE\7XNH\¶V569 
multiple comparison test. ***P<0.001, ****P<0.0001 when comparing Hh-infected and 570 
uninfected mice (A-B) or when compared to uninfected mice (C). 571 
 572 
Figure 2. Large intestinal CD11b+ myeloid cells from Hh-infected Il10±/± mice secrete 573 
elevated amounts of pro-inflammatory cytokines following TLR stimulation. Il10±/± mice 574 
were inoculated with Hh, and LP cells were isolated from pooled caecum and colon 2 weeks 575 
later. Uninfected mice were included as controls. (A-B) Large intestinal LP cells were cultured 576 
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in medium alone or stimulated with 10 Pg/ml Pam3CSK4 for 4 hours with 10 Pg/ml brefeldin A 577 
during the last 3 hours, and then stained for CD45, CD11b, and TNFD or appropriate isotype 578 
control. Dot plots in A are gated on CD45+CD11b+ LP cells from uninfected (Uninf.; upper 579 
panels) and 2-week Hh-infected Il10±/± mice (lower panels), and numbers (+ SD) of TNFD+ 580 
CD11b+ cells per mouse in B were calculated from the percentages in A and the total number 581 
of cells isolated from each mouse. Data in A-B are representative of two independent 582 
experiments performed with 3 individual mice per group. One-way ANOVA followed by 583 
7XNH\¶VPXOWLSOHFRPSDULVon test. **P<0.01 and ****P<0.0001. (C) Large intestinal LP CD11b+ 584 
myeloid cells were FACS-purified from uninfected (white bars) and 2-week Hh-infected (black 585 
bars) Il10±/± mice and stimulated in vitro with LPS (10 Pg/ml), Pam3CSK4 (10 Pg/ml), or 586 
SHelAg (10 Pg/ml) or cultured in medium alone. After 24 hours, supernatants were collected 587 
and analyzed for the presence of IL-12p40, IL-6, and TNFD.  Bars represent mean + SD of 588 
quadruplicate (IL-12p40 and IL-6) or duplicate (TNFa) ELISA values (where each value 589 
represents a separate culture) combined from two independent experiments. 590 
 (D) RT-qPCR analysis of IL-12p35 (Il12a), IL-12p40 (Il12b), and IL-23p19 (Il23a) transcripts 591 
relative to HPRT in sorted CD11b+ cells from uninfected (white bars) or 2-week Hh-infected 592 
(black bars) Il10±/± mice. Bars represent means + SD of three (for uninfected mice) and four 593 
(for Hh-infected mice) individual experiments, each consisting of cells pooled from 5-6 mice. 594 
Mann Whitney test. *P<0.05. 595 
 596 
Figure 3. Composition of the myeloid compartment in Hh-infected Il10±/± mice. WT and 597 
Il10±/± mice were inoculated with Hh and colonic LP cells were isolated 2 weeks later and 598 
examined by flow cytometry. Uninfected mice were included as controls. (A) Relative 599 
frequencies amongst total colonic CD11b+ cells of Ly6G+ neutrophils, SSChi MHCII± 600 
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eosinophils, CD64± CD11c+ MHCII+ CD11b+ DC and Ly6C/MHCII-defined cells of the CD64+ 601 
monocyte/macrophage compartment (Ly6ChiMHCII±, Ly6C+MHCII+, Ly6C±MHCII+) from 602 
uninfected or Hh-infected WT and Il10±/± mice. (B-C) Absolute numbers of Ly6G+ neutrophils 603 
(B) and SSChi MHCII± eosinophils (C) per colon of uninfected or Hh-infected WT and Il10±/± 604 
mice. (D) Representative expression of Ly6C and MHCII by CD11b+Ly6G±SSCloCD64+ cells 605 
from uninfected or Hh-infected WT and Il10±/± mice. Bar graph shows the frequency amongst 606 
CD11b+Ly6G±SSCloCD64+ cells of Ly6ChiMHCII±, Ly6C+MHCII+ and Ly6C±MHCII+ cells. (E) 607 
Absolute numbers of Ly6ChiMHCII±, Ly6C+MHCII+ and Ly6C±MHCII+ cells per colon of 608 
uninfected or Hh-infected WT and Il10±/± mice. Data are from one of two independent 609 
experiments performed. Bars represent the mean + SD of 4 individual mice per group. One-610 
ZD\$129$IROORZHGE\7XNH\¶VPXOWLSOHFRPSDULVRQWHVW30.0001  611 
 612 
Figure 4. Monocyte differentiation is dysregulated in anti-IL-10R-treated Hh-infected 613 
colitic Cx3cr1+/gfp mice. Cx3cr1+/gfp mice were inoculated with Hh and treated weekly with 614 
anti-IL-10R to induce colitis. The composition of the colonic myeloid compartment was then 615 
examined at 14, 41 and 77 days post infection and compared to uninfected mice or mice 616 
given Hh alone. (A-B) Absolute numbers of total CD45+ (A) and CD11b+ cells (B) per colon of 617 
Hh/anti-IL-10R-treated mice 14, 41 and 77 days after infection, compared with control mice 618 
(uninfected and Hh alone; data pooled from day 14-77 for these groups). (C) Relative 619 
frequencies amongst total colonic CD11b+ cells of Ly6G+ neutrophils, SSChiMHCII± 620 
eosinophils, F4/80±CD11c+MHCII+CD11b+ DC and Ly6C/MHCII-defined cells of the F4/80+ 621 
monocyte/mI compartment (Ly6ChiMHCII±, Ly6C+MHCII+, Ly6C±MHCII+) of mice as in A. (D-622 
E) Representative expression of Ly6C and MHCII by CD11b+Ly6G±SSCloF4/80+ cells (D) and 623 
absolute numbers of Ly6ChiMHCII±, Ly6C+MHCII+ and Ly6C±MHCII+ cells per colon (E) of 624 
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mice as in A. (F) Representative expression of CX3CR1-GFP by Ly6C±MHCII+ cells from 625 
uninfected mice, mice inoculated with Hh alone, and mice receiving Hh plus anti-IL-10R when 626 
analysed at 14, 41 and 77 post inoculation. The histograms for the uninfected and Hh alone 627 
are taken from the day 14 experiment.  (G) Absolute numbers of CX3CR1int (top panel) and 628 
CX3CR1hi (bottom panel) Ly6C± MHCII+ cells per colon of mice as in A. Data are from one 629 
experiment and bars represent the mean + SD of 4 individual mice per group. One-way 630 
$129$IROORZHGE\7XNH\¶VPXOWLSOHFRPSDULVRQWHVW *P<0.05, **P<0.01, ***P<0.001. 631 
 632 
Figure 5. Colonic CX3CR1int monocytes/mIs produce pro-inflammatory mediators 633 
during Hh colitis. Cx3cr1+/gfp mice were inoculated with Hh and treated weekly with anti-IL-634 
10R to induce colitis. Two weeks later colonic LP CD64+CX3CR1int and CD64+CX3CR1hi cells 635 
(both pre-gated on CD45+CD11b+Ly6G±SiglecF±) were FACS-purified and processed for RT-636 
qPCR analysis of pro-inflammatory mediators. Uninfected mice, mice given Hh alone, and 637 
mice given anti-IL-10R alone were included as controls. Transcript levels of IL-1E (Il1b) (A), 638 
iNOS (Nos2) (B), IL-23 (Il23a) (C) and IL-12p35 (Il12a) (D) relative to TATA-binding protein 639 
(TBP) in uninfected, Hh alone, anti-IL-10R alone, and Hh plus anti-IL-10R groups. Each 640 
symbol represents a pool of 3 mice (for uninfected, Hh alone, and anti-IL-10R alone) or 641 
individual mice (for Hh plus anti-IL-10R). Data are pooled from two individual experiments. 642 
8QSDLUHG6WXGHQW¶VWWHVW*P<0.05, **P<0.01, ***P<0.001. 643 
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